JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266475

Human ILKAP knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ILKAP KO cell line available to order. KO validated by Western blot. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 5 bp deletion in exon 2.

View Alternative Names

DKFZp434J2031, FLJ10181, ILKAP2, ILKAP3, ILKAP_HUMAN, Integrin linked kinase associated phosphatase, Integrin linked kinase associated serine/threonine phosphatase, Integrin-linked kinase-associated serine/threonine phosphatase 2C, MGC4846, PP2C-delta, Protein phosphatase 2c delta isozyme

2 Images
Western blot - Human ILKAP knockout HEK-293T cell line (AB266475)
  • WB

Lab

Western blot - Human ILKAP knockout HEK-293T cell line (AB266475)

Lanes 1-4 : Merged signal (red and green). Green - ab196013 observed at 49 kDa. Red - loading control ab8245 observed at 36 kDa.

ab196013 Anti-ILKAP antibody [EPR16145] was shown to specifically react with ILKAP in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266475 (knockout cell lysate ab258000) was used. Wild-type and ILKAP knockout samples were subjected to SDS-PAGE. ab196013 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4° at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ILKAP antibody [EPR16145] (<a href='/en-us/products/primary-antibodies/ilkap-antibody-epr16145-ab196013'>ab196013</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

ILKAP knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human ILKAP knockout HEK-293T cell line (ab266475)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

HAP1 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 43 kDa

Observed band size: 49 kDa

false

Sanger Sequencing - Human ILKAP knockout HEK-293T cell line (AB266475)
  • Sanger seq

Unknown

Sanger Sequencing - Human ILKAP knockout HEK-293T cell line (AB266475)

Homozygous : 5 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 5 bp deletion in exon 2

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266475-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266475 Human ILKAP knockout HEK-293T cell line", "number":"AB266475-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266475-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266475 Human ILKAP knockout HEK-293T cell line", "number":"AB266475-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ILKAP
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ILKAP also known as integrin-linked kinase-associated phosphatase is a 43 kDa protein phosphatase. It regulates cell signaling pathways by dephosphorylating specific substrates. It is expressed in various tissues including the heart brain and skeletal muscle. ILKAP specifically interacts with the integrin-linked kinase (ILK) impacting cytoskeletal dynamics and cell adhesion processes.
Biological function summary

The phosphatase activity of ILKAP plays a role in cellular adhesion and movement. ILKAP participates in cellular processes by associating with the ILK complex which includes other key proteins like paxillin and parvin. By modulating the phosphorylation state of substrates within this complex ILKAP influences focal adhesion dynamics and cytoskeletal organization which are critical for maintaining cellular architecture and motility.

Pathways

ILKAP acts within the integrin signaling and Wnt signaling pathways. These pathways are important in regulating cell movement differentiation and survival. ILKAP interacts with proteins like β-catenin in the Wnt pathway influencing gene expression critical for cell fate determination. Additionally ILKAP works alongside ILK in the integrin signaling pathway to affect cellular responses like proliferation and migration.

ILKAP has connections to cancer and cardiovascular diseases. Its regulatory role in cell adhesion and movement links it to cancer metastasis where the altered adhesion leads to the spread of cancer cells. ILKAP also interacts with ILK influencing mechanisms related to tissue remodeling and inflammation in cardiovascular diseases. These associations highlight ILKAP as a potential target for therapeutic intervention in these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com